Cambridge Investment Research Advisors »

Xeris Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $75k 34k 2.20
2023-12-31 $76k 32k 2.36
2023-09-30 $66k 36k 1.85

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
MPM Oncology Impact Management
Geode Capital Management
Rosalind Advisors
Millennium Management
Nuveen Asset Management
CenterBook Partners
Morgan Stanley
Northern Trust
AQR Capital Management
Redmile Group
Ameriprise Financial
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Xeris Pharmaceuticals